Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP749355.RAH0mE2Y5cq8qrEaT33DpArEfwOUA6jkRlkVvCq5ML_k0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP749355.RAH0mE2Y5cq8qrEaT33DpArEfwOUA6jkRlkVvCq5ML_k0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP749355.RAH0mE2Y5cq8qrEaT33DpArEfwOUA6jkRlkVvCq5ML_k0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP749355.RAH0mE2Y5cq8qrEaT33DpArEfwOUA6jkRlkVvCq5ML_k0130_provenance.
- befree-2016 importedOn "2016-02-19" NP749355.RAH0mE2Y5cq8qrEaT33DpArEfwOUA6jkRlkVvCq5ML_k0130_provenance.
- NP749355.RAH0mE2Y5cq8qrEaT33DpArEfwOUA6jkRlkVvCq5ML_k0130_assertion wasGeneratedBy ECO_0000203 NP749355.RAH0mE2Y5cq8qrEaT33DpArEfwOUA6jkRlkVvCq5ML_k0130_provenance.
- NP749355.RAH0mE2Y5cq8qrEaT33DpArEfwOUA6jkRlkVvCq5ML_k0130_assertion wasDerivedFrom befree-2016 NP749355.RAH0mE2Y5cq8qrEaT33DpArEfwOUA6jkRlkVvCq5ML_k0130_provenance.
- NP749355.RAH0mE2Y5cq8qrEaT33DpArEfwOUA6jkRlkVvCq5ML_k0130_assertion SIO_000772 19578752 NP749355.RAH0mE2Y5cq8qrEaT33DpArEfwOUA6jkRlkVvCq5ML_k0130_provenance.
- NP749355.RAH0mE2Y5cq8qrEaT33DpArEfwOUA6jkRlkVvCq5ML_k0130_assertion evidence source_evidence_literature NP749355.RAH0mE2Y5cq8qrEaT33DpArEfwOUA6jkRlkVvCq5ML_k0130_provenance.
- NP749355.RAH0mE2Y5cq8qrEaT33DpArEfwOUA6jkRlkVvCq5ML_k0130_assertion description "[Both the NIH-OVCAR-3 cell line and 70% of RB+/p16+ ovarian tumors showed abnormally elevated levels of the full-length cyclin E protein (EL1) in addition to several low molecular weight (LMW) isoforms of cyclin E. Using small interference RNA (siRNA), we have inhibited the synthesis of cyclin EL1 protein by approximately 80% and eliminated the LMW isoforms in NIH-OVCAR-3 ovarian cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP749355.RAH0mE2Y5cq8qrEaT33DpArEfwOUA6jkRlkVvCq5ML_k0130_provenance.